Armephaco JSC

Armephaco JSC Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is -1,012.64 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 538.79 % — a change of -287.95% (lower).

Cash Conversion

-1,012.64 %

YoY

-287.95%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Armephaco JSC is 2024 -1,012.64 % . Cash Conversion Rate (OCF/Net Income) of Armephaco JSC was 2023 538.79 % . It decreases by -287.95% lower compared to the previous year.

The Armephaco JSC Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2017
0.71 VND
Jan 1, 2018
-204.11 VND
Jan 1, 2019
50.36 VND
Jan 1, 2020
-205.80 VND
Jan 1, 2021
1,312.83 VND
Jan 1, 2022
286.79 VND
Jan 1, 2023
538.79 VND
Jan 1, 2024
-1,012.64 VND
The Armephaco JSC Cash Conversion history
YEARCash ConversionYoY
-1,012.64 %-287.95%
538.79 %+87.87%
286.79 %-78.16%
1,312.83 %-737.91%
-205.80 %-508.66%
50.36 %-124.67%
-204.11 %-28,705.93%
0.71 %-100.09%
-817.34 %-93,507.80%
0.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Cash Conversion Rate (OCF/Net Income) of Armephaco JSC is -1,012.64 % in 2024.

Cash Conversion Rate (OCF/Net Income) of Armephaco JSC changed from 538.79 % to -1,012.64 %, representing a -287.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Armephaco JSC

All Key Metrics — Armephaco JSC